Superworth

Aurinia Pharmaceuticals profit margin AUPH

Gross, operating and net profit as a share of revenue over the last twelve months, from 2022.

Net margin, 12 months
97.7%
Operating margin, 12 months
48.6%
Net margin on a year earlier
+68.4 pts
Peer median
13.3%

Over the twelve months to Sep 30, 2026, Aurinia Pharmaceuticals kept 97.7% of its revenue as net profit, with an operating margin of 48.6% and a gross margin of 90.6%.

The median for 10 large drugmakers of a similar size is 13.3%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025n/a37.1%88.5%
FY20242.4%−2.0%88.0%
FY2023−44.5%−52.2%91.9%
FY2022−80.7%−83.2%95.8%
FY2021n/an/a97.6%
FY2020n/an/a100.0%
FY2019n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q3 FY2697.7%+68.4 pts48.6%
Q2 FY26n/an/a48.4%
Q1 FY26100.0%+83.9 pts41.7%
Q4 FY25n/an/a37.1%
Q3 FY2529.3%+39.5 pts26.3%
Q2 FY2523.3%+47.6 pts20.0%
Q1 FY2516.1%+48.8 pts12.3%
Q4 FY242.4%+46.9 pts−2.0%
Q3 FY24−10.2%+38.4 pts−14.8%
Q2 FY24−24.3%+21.1 pts−29.3%
Q1 FY24−32.7%+33.2 pts−39.4%
Q4 FY23−44.5%+36.3 pts−52.2%

Against its peers

Companies in Drug Manufacturers - General nearest Aurinia Pharmaceuticals' size, closest first, today.

Where Aurinia Pharmaceuticals ranks

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Aurinia Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.